{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:51:29Z","timestamp":1782489089471,"version":"3.54.5"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A hub-and-spokes model strengthens care for Epidermolysis Bullosa by combining specialized expertise with community clinics. Genetic and genomic diagnostics power personalized treatment, whilst telemedicine improves access and affordability of patient care. This integrated system delivers equitable and patient-centered care, reducing burden and improving outcomes for individuals with rare genetic diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a before-and-after observational study conducted at the Centre for Human Genetics in Bangalore, between January 2020 and August 2025. Patients with confirmed or suspected Epidermolysis Bullosa (EB) were referred, either by spoke-level practitioners or family members, to a teleconsultation with specialized dermatologists. Clinical data, including family history, were securely documented, and a multidisciplinary team was engaged when further intervention was required. Continuity of care was facilitated through a HIPAA-compliant mobile application, enabling families to maintain communication and follow-up. The impact of the program was evaluated by analyzing its geographical reach, patient evaluation, and comparative medical costs before and after implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Developing a standardized diagnostic framework and care pathways for the heterogeneous genetic condition Epidermolysis Bullosa (EB) across a large geographic region addressed a critical gap in the healthcare system. Within our program, 271 patients were enrolled, comprising EB simplex (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200967), junctional EB (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200969), dystrophic EB (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009104), and Kindler syndrome (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097). Geographical data, available for 41 patients, demonstrated that most (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200931, 75.6%) resided within a 600\u2005km radius of the central hub, while the most distant patient was located 3125\u2005km away, underscoring both the initiative's reach and accessibility. Importantly, implementation of the program resulted in a statistically significant reduction in direct medical costs, with a median savings of Rs 2625 (IQR: \u22121212\u20139025), as confirmed by a two-tailed Wilcoxon signed rank test (W\u2009=\u2009143,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200932,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0225). These findings highlight the feasibility and impact of centralized diagnostic and care models in improving access and reducing the economic burden for patients with EB.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patient care for Epidermolysis Bullosa has focused beyond economic benefits; the model demonstrates how technology can enhance equity in healthcare delivery. Telemedicine and genomic technologies bridge critical gaps in specialized care, particularly for complex conditions such as EB across wide geographic regions. A centralized diagnostic and care framework across wide geographic regions allows for statistically significant reductions in direct medical costs<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fdgth.2026.1848667","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:22:33Z","timestamp":1782487353000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integration of a tele-dermatology model for Epidermolysis Bullosa improves patient outreach: a before and after observational study"],"prefix":"10.3389","volume":"8","author":[{"given":"Aditya","family":"Viswanath","sequence":"first","affiliation":[{"name":"Leicester Medical School, University of Leicester","place":["Leicester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Dr. B R Ambedkar Medical College and Hospital","place":["Bengaluru, India"]},{"name":"Centre for human Genetics","place":["Bengaluru, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Srinivasa","sequence":"additional","affiliation":[{"name":"Department of Dermatology Sri Madhusudan Sai Institute of Medical Sciences and Research","place":["Chikkaballapur, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Jose","sequence":"additional","affiliation":[{"name":"Department of Dermatology Sri Madhusudan Sai Institute of Medical Sciences and Research","place":["Chikkaballapur, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silji","family":"Jibins","sequence":"additional","affiliation":[{"name":"Centre of Human Genetics","place":["Bengaluru, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mendith","sequence":"additional","affiliation":[{"name":"Centre of Human Genetics","place":["Bengaluru, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utsav","family":"Munnoli","sequence":"additional","affiliation":[{"name":"Centre of Human Genetics","place":["Bengaluru, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Jubba","sequence":"additional","affiliation":[{"name":"Dermatopathologist, Delhi Dermath Laboratory","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guruduta","family":"Baraka","sequence":"additional","affiliation":[{"name":"Department of Human Genetics National, NIMHANS","place":["Bangalore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Hiremagalore","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Alabama","place":["Birmingham, AL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jdermsci.2021.11.004","article-title":"Current topics in epidermolysis bullosa: pathophysiology and therapeutic challenges","volume":"104","author":"Natsuga","year":"2021","journal-title":"J Dermatol Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0289558","DOI":"10.1371\/journal.pone.0289558","article-title":"Clinical and allelic heterogeneity in dystrophic epidermolysis bullosa- lessons from an Indian cohort","volume":"18","author":"Gupta","year":"2023","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jdv.17012","article-title":"Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB registry: eB more common than previously assumed?","volume":"35","author":"Baardman","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/jdv.18637","article-title":"Epidemiology of inherited epidermolysis bullosa in Germany","volume":"37","author":"Has","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/bjd.20958","article-title":"The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database","volume":"186","author":"Petrof","year":"2022","journal-title":"Br J Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s13023-024-03377-6","article-title":"Navigating health policies and programs in India: exploring opportunities to improve rare disease management and orphan drug research","volume":"19","author":"Mishra","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/bjd.13305","article-title":"Immunofluorescence mapping in inherited epidermolysis bullosa: a study of 86 cases from India","volume":"172","author":"Hiremagalore","year":"2015","journal-title":"Br J Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13023-022-02433-3","article-title":"A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex","volume":"17","author":"So","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13023-021-01811-7","article-title":"A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa","volume":"16","author":"Tang","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s13023-022-02509-0","article-title":"Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa","volume":"17","author":"Feinstein","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1002\/ski2.314","article-title":"Costs of UK community care for individuals with recessive dystrophic epidermolysis bullosa: findings of the prospective epidermolysis Bullosa longitudinal evaluation study","volume":"4","author":"Jeffs","year":"2024","journal-title":"Skin Health Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13643-024-02655-5","article-title":"Teledermatology: an evidence map of systematic reviews","volume":"13","author":"Chow","year":"2024","journal-title":"Syst Rev"},{"key":"B13","year":""},{"key":"B14","doi-asserted-by":"publisher","first-page":"e068207","DOI":"10.1136\/bmjopen-2022-068207","article-title":"Diagnostic reliability in teledermatology: a systematic review and a meta-analysis","volume":"13","author":"Bourkas","year":"2023","journal-title":"BMJ Open"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jaad.2020.06.1023","article-title":"Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-consensus: recommendations by an international panel of experts","volume":"83","author":"Murrell","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1089\/tmj.2018.0130","article-title":"Use of teledermatology to improve dermatological access in rural areas","volume":"25","author":"Coustasse","year":"2019","journal-title":"Telemed J E Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4269\/ajtmh.23-0218","article-title":"Teledermatology to improve access to and quality of skin care in eastern Indonesia","volume":"110","author":"Adella","year":"2024","journal-title":"Am J Trop Med Hyg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"104977","DOI":"10.1016\/j.ejmg.2024.104977","article-title":"Telehealth for rare disease care, research, and education across the globe: a review of the literature by the IRDiRC telehealth task force","volume":"72","author":"Chen","year":"2024","journal-title":"Eur J Med Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3390\/children11111401","article-title":"Perspectives and challenges of telemedicine and artificial intelligence in pediatric dermatology","volume":"11","author":"Zama","year":"2024","journal-title":"Children (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s13023-024-03328-1","article-title":"Economic burden and health-related quality of life in patients with epidermolysis bullosa in Spain","volume":"19","author":"Aranda-Reneo","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.47176\/mjiri.35.146","article-title":"Economic burden of epidermolysis Bullosa disease in Iran","volume":"35","author":"Forghani","year":"2021","journal-title":"Med J Islam Repub Iran"},{"key":"B22","doi-asserted-by":"publisher","first-page":"787135","DOI":"10.3389\/fpubh.2022.787135","article-title":"The cost-effectiveness of digital health interventions: a systematic review of the literature","volume":"10","author":"Gentili","year":"2022","journal-title":"Front Public Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jaad.2020.01.065","article-title":"Clinical effectiveness and cost-effectiveness of teledermatology: where are we now, and what are the barriers to adoption?","volume":"83","author":"Wang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0223004","DOI":"10.1371\/journal.pone.0223004","article-title":"Costs and cost-effectiveness analyses of mCARE strategies for promoting care seeking of maternal and newborn health services in rural Bangladesh","volume":"14","author":"Jo","year":"2019","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e17066","DOI":"10.2196\/17066","article-title":"Costing and cost-effectiveness of a Mobile health intervention (ImTeCHO) in improving infant mortality in tribal areas of gujarat, India: cluster randomized controlled trial","volume":"8","author":"Modi","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"key":"B26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12962-018-0110-2","article-title":"Cost effectiveness of mHealth intervention by community health workers for reducing maternal and newborn mortality in rural uttar pradesh, India","volume":"16","author":"Prinja","year":"2018","journal-title":"Cost Eff Resour Alloc"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1848667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:22:37Z","timestamp":1782487357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1848667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":26,"alternative-id":["10.3389\/fdgth.2026.1848667"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2026.1848667","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1848667"}}